BR0107058A - Process for preparing a vaccine for the treatment of tuberculosis and other intracellular diseases and infections and the vaccine produced by such a process - Google Patents

Process for preparing a vaccine for the treatment of tuberculosis and other intracellular diseases and infections and the vaccine produced by such a process

Info

Publication number
BR0107058A
BR0107058A BR0107058-4A BR0107058A BR0107058A BR 0107058 A BR0107058 A BR 0107058A BR 0107058 A BR0107058 A BR 0107058A BR 0107058 A BR0107058 A BR 0107058A
Authority
BR
Brazil
Prior art keywords
vaccine
tuberculosis
infections
preparing
treatment
Prior art date
Application number
BR0107058-4A
Other languages
Portuguese (pt)
Inventor
Naim Javed Agrewala
Naresch Sharma
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of BR0107058A publication Critical patent/BR0107058A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE UMA VACINA PARA O TRATAMENTO DA TUBERCULOSE E DE OUTRAS DOENçAS E INFECçõES INTRACELULARES E A VACINA PRODUZIDA ATRAVéS DESSE PROCESSO". A presente invenção refere-se a um processo para a preparação de uma vacina contra a tuberculose e outros patógenos intracelulares, de modo mais específico, neste caso, os patógenos Mycobacterium tuberculosis e Salmonella."PROCESS FOR PREPARING A VACCINE FOR TREATMENT OF TUBERCULOSIS AND OTHER INTRACELLULAR DISEASES AND INFECTIONS AND THE VACCINE PRODUCED THROUGH THIS PROCESS". The present invention relates to a process for the preparation of a vaccine against tuberculosis and other intracellular pathogens, more specifically in this case the pathogens Mycobacterium tuberculosis and Salmonella.

BR0107058-4A 2001-03-23 2001-03-23 Process for preparing a vaccine for the treatment of tuberculosis and other intracellular diseases and infections and the vaccine produced by such a process BR0107058A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2001/000047 WO2002076500A1 (en) 2001-03-23 2001-03-23 Vaccine for the treatment of tubercolosis and other intracellular infections diseases

Publications (1)

Publication Number Publication Date
BR0107058A true BR0107058A (en) 2005-02-15

Family

ID=11076318

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107058-4A BR0107058A (en) 2001-03-23 2001-03-23 Process for preparing a vaccine for the treatment of tuberculosis and other intracellular diseases and infections and the vaccine produced by such a process

Country Status (3)

Country Link
CN (1) CN100496605C (en)
BR (1) BR0107058A (en)
WO (1) WO2002076500A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100354002C (en) * 2005-05-31 2007-12-12 中国人民解放军第三军医大学第一附属医院 New type of cell vaccine with heteroimmune cell as cell vector and its prepn process
CN108743931B (en) 2018-05-02 2022-08-16 成都威斯克生物医药有限公司 Vaccine against tuberculosis and its preparation method and use
TR202006914A1 (en) * 2020-05-04 2021-11-22 Univ Yeditepe USE OF EXTRAcellular vesicles as an immunoprophylactic and immunotherapeutic for leishmaniasis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2302747B1 (en) * 1975-03-03 1978-09-22 Inst Nat Sante Rech Med PROCESS FOR OBTAINING, FROM MACROPHAGES OF MAMMALS, AN ACTIVE THERAPEUTIC PRODUCT, IN PARTICULAR, WITH REGARD TO HUMAN TUMOR CELLS AND THERAPEUTIC PRODUCT THUS OBTAINED
EP0223218A3 (en) * 1985-11-22 1989-05-17 Christiane Prof. Dr. Stang-Voss Conditioned macrophages and process for their preparation

Also Published As

Publication number Publication date
CN1420784A (en) 2003-05-28
WO2002076500A1 (en) 2002-10-03
CN100496605C (en) 2009-06-10

Similar Documents

Publication Publication Date Title
BRPI0410503A (en) use of ivermectin for the manufacture of a topical pharmaceutical composition, topical composition and use of the composition
PT1187629E (en) ADJUVANT COMPOSITION THAT UNDERSTANDS SAPONIN AND AN IMMUNOSTIMULATOR OLIGONUCLEOTIDE
BRPI0406427A (en) Process for the preparation of roflumilast
BRPI0415167A (en) amine compound as ion channel ligands and uses thereof
DOP2002000429A (en) IMIDAZOTRIAZINAS
CY1107146T1 (en) METHODS FOR THE PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE (AD)
BRPI0416205A (en) use of antibiotics as vaccine adjuvants
BR0210139A (en) Pharmaceutical Compositions
ECSP034732A (en) DERIVATIVE OF PHENETHANOLAMINE FOR THE TREATMENT OF RESPIRATORY DISEASES
BR0311126A (en) Compositions and method for treating infection in cattle and pigs
MY146351A (en) Compositions for treating infection in cattle and swine
BR0010456A (en) Use of xenon to treat neurointoxications, inhalable preparation and method for producing an inhalable preparation
BR0209845A (en) Oxcarbazepine dosage forms and processes for preparing them
PT1414816E (en) FLIBANSERIN STABILIZABLE POLYMORPHINE, TECHNICAL PROCESS FOR PREPARING AND USING THE PREPARATION OF MEDICINES
BR0317888A (en) Human Growth Hormone Crystals and Processes for Preparing Them
BRPI0408863A (en) compound, pharmaceutical composition, method for treating diseases, and use of a compound.
BR0306258A (en) Composition, method for hair treatment and method for maintaining the shape and / or definition of hair curling
BRPI0415179A (en) amide derivatives such as ion channel ligands and pharmaceutical compositions and methods of employing them
BR0316723A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
BRPI0208468B8 (en) amlodipine camsylate and process for its preparation
BRPI0516224A (en) food product containing one or more living microorganisms and at least one bioactive food ingredient of interest, process for preparing it, and use of a food product
BR0211739A (en) New crystalline polymorphic forms of lercanidipine hydrochloride and process for preparing them
BR0301667A (en) Process for the preparation of high purity emulsion polymers
BR0307783A (en) Compositions and methods for treating epithelial and retinal tissue disorders
BRPI0415781A (en) Method for treating diabetes in a patient and pharmaceutical kit

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements